CRISPR/Cas9 article from Eskeland lab in Aftenposten - Viten

Martine Mesel Isom and Ragnhild Eskeland are featured in "Viten" in the National newspaper Aftenposten with their article on CRISPR/Cas9. 

Illustration: Naima Azouzi

Illustration: Naima Azouzi.

Their article focuses on the increasing safety in using gene editing tools for research and in development of future therapeutics.

Synopsis: "The use of CRISPR/Cas9 a gene editing tool has shown promising results for two types of blood diseases, and clinical trials for other diseases are ongoing. The novel Prime Editing tool has overcome some limitations of the CRISPR/Cas9. National regulations need to be in place to ensure the ethical and responsible application of this emerging technology in patient treatment."


For more details, see (in Norwegian). 


Published Apr. 2, 2020 2:54 PM - Last modified Apr. 2, 2020 3:21 PM